SCHEMBL16760581

SCHEMBL16760581

CCOC(=O)C(C)OC(=O)CC(C)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 2/20 0.43
GAA P10253 2/20 0.43
SI P14410 2/20 0.43
MGAM2 Q2M2H8 2/20 0.43
ALDH1A1 P00352 4/20 0.39
LMNA P02545 2/20 0.39
HSD17B10 Q99714 1/20 0.39
HPGD P15428 1/20 0.37
MAPT P10636 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TRPA1 O75762 1/20 0.35
KMT2A Q03164 3/20 0.35
POLB P06746 1/20 0.34
ALOX15 P16050 1/20 0.33
KDM4E B2RXH2 1/20 0.33
SOAT1 P35610 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16760579 1.00 MGAM (0.43) MGAMGAASIMGAM2ALDH1A1
SCHEMBL2896443 0.83 MGAM (0.52) MGAMGAASIMGAM2ALDH1A1
SCHEMBL2886197 0.83 MGAM (0.52) MGAMGAASIMGAM2ALDH1A1
SCHEMBL2886194 0.83 MGAM (0.52) MGAMGAASIMGAM2ALDH1A1
SCHEMBL18832132 0.82 GAA (0.44) MGAMGAASIMGAM2ALDH1A1
SCHEMBL16759881 0.82 MGAM (0.44) MGAMGAASIMGAM2ALDH1A1
SCHEMBL22971403 0.82 CYP1A2 (0.41) MGAMGAASIMGAM2ALDH1A1
SCHEMBL16759680 0.82 MGAM (0.44) MGAMGAASIMGAM2ALDH1A1
SCHEMBL16759683 0.82 MGAM (0.44) MGAMGAASIMGAM2ALDH1A1
SCHEMBL1396422 0.81 MGAM (0.42) MGAMGAASIMGAM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9617252-B2 Processes for preparing dihydropyrimidine derivatives and intermediates thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2017-04-11 US disclosed
EP-3074393-A1 PROCESSES FOR PREPARING DIHYDROPYRIMIDINE DERIVATIVES AND INTERMEDIATES THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2016-10-05 EP disclosed
US-20160264562-A1 PROCESSES FOR PREPARING DIHYDROPYRIMIDINE DERIVATIVES AND INTERMEDIATES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-09-15 US disclosed
WO-2015078391-A1 PROCESSES FOR PREPARING DIHYDROPYRIMIDINE DERIVATIVES AND INTERMEDIATES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2015-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160264562-A1 PROCESSES FOR PREPARING DIHYDROPYRIMIDINE DERIVATIVES AND INTERMEDIATES THEREOF DPYD, DHPS, DHODH MGAM 2386/4885GAA 819/4885SI 267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.